Beauty Tech Deal: Cellink to acquire Cytena via Cosmetics Design Europe

Produced By Deanna Utroske, 2

This month, multinational bioprinting technologies company Cellink announced having reached a deal to acquire Cytena for €30.25 million. The Freiburg, Germany – based venture specialises in single-cell printing technology. And the deal will expand Cellink’s capabilities in both pharma and cosmetics.

Cellink got its start in 2016 and is headquartered in Boston, Massachusetts, (in the US) where a lot of biotech businesses are located. The company makes and commercializes bioprinting technologies for use in academic research and industry. Bioprinting is essentially 3-dimentional printing technology that incorporates live cells and is used to create tissue and other components.

Read more…

Recent Posts

StratiCELL expands its testing offer to women’s health

The human vaginal mucosa is comprised of a protective multilayered epithelium with a squamous, stratified…

The rise of vegan beauty and its challenges by Integra

Veganism is no longer just a dietary choice; it’s a full lifestyle movement that influences…

EU to host webinar on Ecolabel standards for sustainable cosmetics via Personal Care Insights

The European Commission (EC) is hosting a free, one-hour webinar, “When Beauty Meets Green: The…